Aprepitant Capsules and Cisatracurium Besylate Injection
Determining the interaction of Aprepitant Capsules and Cisatracurium Besylate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: cisatracurium
Brand name: Nimbex
Synonyms: Cisatracurium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Cisatracurium besylate Intravenous
- Aprepitant Capsules-Cisplatin
- Aprepitant Capsules-Cisplatin Intravenous
- Aprepitant Capsules-Citalopram
- Aprepitant Capsules-Citalopram Capsules
- Aprepitant Capsules-Citalopram Hydrobromide
- Cisatracurium Besylate Injection-Aprepitant Injection
- Cisatracurium Besylate Injection-Aprepitant Intravenous
- Cisatracurium Besylate Injection-Aprepitant Oral Suspension
- Cisatracurium Besylate Injection-Aprepitant/Fosaprepitant Dimeglumine
- Cisatracurium Besylate Injection-Apresazide
- Cisatracurium Besylate Injection-Apresoline